Search results

Whether it's through stocks, bonds, ETFs, or other types of securities, all investors love seeing their portfolios score big returns. But for income investors, generating consistent cash flow from

All investors love getting big returns from their portfolio, whether it's through stocks, bonds, ETFs, or other types of securities. However, when you're an income investor, your primary focus is

The Kraft Heinz Company KHC is likely to witness top and bottom-line declines when it reports second-quarter 2026 earnings on Aug. 5, before the opening bell. The Zacks Consensus Estimate for

Novo Nordisk NVO is scheduled to report its second-quarter 2026 results on Aug. 5, 2026, before the opening bell. The Zacks Consensus Estimate for quarterly revenues in the to-be-reported quarter is

Investors interested in stocks from the Computers - IT Services sector have probably already heard of Amdocs (DOX) and Roper Technologies (ROP). But which of these two companies is the best option

Celsius Holdings, Inc. CELH is likely to witness top-line growth when it reports second-quarter 2026 earnings on Aug. 6. The Zacks Consensus Estimate for revenues is pegged at $887.7 million

Thermo Fisher Scientific Inc. TMO raised its 2026 outlook after second-quarter earnings and revenues exceeded expectations. The update reflects stronger customer activity, better acquisition

e.l.f. Beauty, Inc. ELF is likely to witness top-line growth when it reports first-quarter fiscal 2027 earnings on Aug. 5. The Zacks Consensus Estimate for revenues is pegged at $425.7 million

Ingredion Incorporated INGR has proposed an approximately $5 billion enterprise-value acquisition of Tate & Lyle PLC. The deal could accelerate Ingredion’s shift toward higher-value specialty

EMCOR Group, Inc. EME is producing faster earnings growth, record contracted work and a higher full-year outlook. Those strengths support the case for buying the stock despite its recent

Ingredion Incorporated INGR trades at a sizable discount, while its higher-value specialty portfolio continues to improve. That combination creates a credible value case.The obstacle is execution

EMCOR Group, Inc. EME shares have declined 12.4% over the past three months even as it delivered sharp earnings growth and analysts raised estimates.The pullback may offer a better entry point, but

The New York Times Company NYT is set to announce its second-quarter 2026 earnings results on Aug. 5, before the market opens. Key focus areas include subscription growth and trends in advertising

EMCOR Group, Inc. EME entered the second half of 2026 with record remaining performance obligations and a sharply higher outlook. The combination could extend its earnings momentum if contracted

Shares of Pagaya Technologies PGY have gained almost 19% since the release of its second-quarter 2026 results on July 30. Quarterly adjusted earnings per share of $1.07 comfortably surpassed the

Pagaya Technologies PGY delivered a strong first half of 2026, driven by record lending activity, robust revenue growth and expanding profitability. In the six months ended June 30, 2026, network

Eli Lilly and Company LLY will report its second-quarter 2026 earnings on Aug. 5, before market open. The Zacks Consensus Estimate for sales and earnings is pegged at $20.26 billion and $6.71 per

Aside from Q2 earnings season reaching its busiest week of the cycle, we’re also upon a new Jobs Week — JOLTS on Tuesday, ADP private-sector payrolls Wednesday and non-farm payrolls from BLS Friday

Starbucks Corporation SBUX raised its fiscal 2026 outlook after stronger comparable sales and margin performance in the third quarter. The higher targets offer the clearest test yet of whether the

For investors seeking momentum, Capital Group U.S. Large Value ETF CGVV is probably on the radar. The fund just hit a 52-week high and is up 26.99% from its 52-week low price of $24.63/share.

But